WS #15806
Holding: newest synthesis is 8d 3h old
Johnson & Johnson shares are tumbling approximately 7% as the company leans toward spinning out its hips-and-knees business and reports earnings impacted by talc litigation resolutions. The market is repricing J&J from a diversified healthcare giant to a leaner entity, with the MedTech segment facing slowed growth as the company restructures its portfolio.
Johnson & Johnson Strategic Shift
Johnson & Johnson shares are tumbling approximately 7% as the company leans toward spinning out its hips-and-knees business and reports earnings impacted by talc litigation resolutions. The market is repricing J&J from a diversified healthcare giant to a leaner entity, with the MedTech segment facing slowed growth as the company restructures its portfolio.